210 related articles for article (PubMed ID: 20013802)
1. Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.
Barakat BM; Wang QE; Han C; Milum K; Yin DT; Zhao Q; Wani G; Arafa el-SA; El-Mahdy MA; Wani AA
Int J Cancer; 2010 Aug; 127(4):977-88. PubMed ID: 20013802
[TBL] [Abstract][Full Text] [Related]
2. Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.
Li B; Gao Y; Rankin GO; Rojanasakul Y; Cutler SJ; Tu Y; Chen YC
Cancer Lett; 2015 Jan; 356(2 Pt B):418-33. PubMed ID: 25304379
[TBL] [Abstract][Full Text] [Related]
3. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
[TBL] [Abstract][Full Text] [Related]
4. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
5. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
[TBL] [Abstract][Full Text] [Related]
7. DDB2 decides cell fate following DNA damage.
Stoyanova T; Roy N; Kopanja D; Bagchi S; Raychaudhuri P
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10690-5. PubMed ID: 19541625
[TBL] [Abstract][Full Text] [Related]
8. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
11. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.
Sun CL; Chao CC
Mol Pharmacol; 2005 Apr; 67(4):1307-14. PubMed ID: 15644494
[TBL] [Abstract][Full Text] [Related]
13. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
[TBL] [Abstract][Full Text] [Related]
14. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.
Huang H; Chen AY; Ye X; Li B; Rojanasakul Y; Rankin GO; Chen YC
Int J Oncol; 2015 Oct; 47(4):1494-502. PubMed ID: 26315556
[TBL] [Abstract][Full Text] [Related]
15. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
Wang R; Ma X; Su S; Liu Y
Future Med Chem; 2018 Aug; 10(16):1947-1955. PubMed ID: 29966441
[TBL] [Abstract][Full Text] [Related]
16. Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines.
Yu L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(2):151-3. PubMed ID: 15315167
[TBL] [Abstract][Full Text] [Related]
17. Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway.
Qin X; Sun L; Wang J
Cell Biol Int; 2017 Oct; 41(10):1110-1118. PubMed ID: 28685895
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
Xu L; Xie Q; Qi L; Wang C; Xu N; Liu W; Yu Y; Li S; Xu Y
Oncol Rep; 2018 Mar; 39(3):985-992. PubMed ID: 29286126
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
Gong TT; Liu XD; Zhan ZP; Wu QJ
Exp Cell Res; 2020 Aug; 393(2):112061. PubMed ID: 32437713
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]